MANTLE CELL LYMPHOMA
Clinical trials for MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental MCL drug trial halted early
Disease control TerminatedThis study tested a new drug called TQB3909 in 19 people with mantle cell lymphoma (MCL) that had come back or stopped responding to treatment. The main goal was to find a safe dose and check for side effects. The trial was ended early, so results are limited.
Matched conditions: MANTLE CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 04:36 UTC
-
Blood cancer transplant study tests safer GVHD prevention
Disease control TerminatedThis study looked at people with blood cancers receiving a stem cell transplant from an unrelated donor. The goal was to compare two drug combinations (cyclosporine plus sirolimus with either MMF or post-transplant cyclophosphamide) to prevent graft-versus-host disease (GVHD), a …
Matched conditions: MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:33 UTC